Novel CSF β-synuclein-specific assays signal early synaptic degeneration in Alzheimer's disease

被引:0
作者
Bayoumy, Sherif [1 ]
Goossens, Julie [2 ]
De Rocker, Charlotte [2 ]
Sie, Senna Y. [1 ]
Barrett, Nolan J. [1 ]
van der Flier, Wiesje M. [3 ,4 ]
Teunissen, Charlotte E. [1 ]
Vanmechelen, Eugeen [3 ]
Verberk, Inge M. W. [1 ]
机构
[1] Vrije Univ Amsterdam, Dept Lab Med, Neurochem Lab, Amsterdam UMC,Amsterdam Neurosci, De Boelelaan 1117,1018 HVm,POB 7057, NL-1007 MB Amsterdam, Netherlands
[2] ADx Neurosci NV, Technol Pk 6, B-9052 Ghent, Belgium
[3] Vrije Univ Amsterdam, Alzheimer Ctr, Dept Neurol, UMC, De Boelelaan 1117, NL-1018 HV Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Dept Epidemiol & Data Sci, UMC, De Boelelaan 1105, NL-1081 HV Amsterdam, Netherlands
关键词
Alzheimer<acute accent>s disease; Preclinical alzheimer's disease; CSF biomarker; beta-Synuclein; Synaptic degeneration; Novel ELISAs; MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; CEREBROSPINAL-FLUID; NATIONAL INSTITUTE; ALPHA-SYNUCLEIN; DEMENTIA; PATHOLOGY; RECOMMENDATIONS; IDENTIFICATION;
D O I
10.1186/s13195-025-01716-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Beta-synuclein (beta-syn), measured at N-terminal epitopes, is an emerging cerebrospinal fluid (CSF) biomarker for synaptic degeneration in Alzheimer's disease (AD). Targeting the mid-region or C-terminus of beta-syn may enhance analytical specificity due to the distinct structures of these regions across the synuclein protein family, unlike targeting the N-terminus, which is conserved across the family. This study aimed to confirm that beta-syn is a promising CSF biomarker in AD, using novel assays designed to target different regions of beta-syn, to investigate whether these regions are differentially affected in AD. Methods We developed two novel CSF beta-syn-specific ELISAs targeting mid-region and C-terminus epitopes and assessed their analytical performance. Using these novel assays in combination with the established N-terminus ELISA, we analyzed a proof-of-concept cohort comprising biomarker-confirmed AD (n = 25) and non-AD subjects (n = 25) and a larger clinical cohort (n = 160) from the Amsterdam Dementia Cohort, wich included 41 individuals with subjective cognitive decline (SCD, controls; AD biomarker negative; 64.3 +/- 3.3 years, 23 females), 39 with SCD (AD biomarker positive; 65.7 +/- 3.1 years, 17 females), 40 with mild cognitive impairment due to AD (MCI-AD; 66.2 +/- 2.9 years, 20 females), and 40 with AD dementia (AD-dem; 65.3 +/- 3.4 years, 20 females). Results Both the mid-region and C-terminus assays demonstrated reliable analytical performance. All assays consistently detected beta-syn in all clinical samples above their limits of detection, with a good average intra-assay coefficient of variation (range of the three assays: 2.7-6.5%CV) in the proof-of-concept cohort and clinical cohort (range of the three assays: 3.9-7.5%CV). CSF beta-syn levels, with all the assays, were significantly elevated in all the AD groups compared with the controls in both cohorts. The diagnostic performance of the assays for distinguishing AD patients from controls was comparable (Delong's p > 0.05, AUC 0.71-0.80). Notably, mid-region beta-syn significantly differentiated SCD-AD patients from AD-dem patients (p = 0.035) and MCI-AD patients at a trend level. Only mid-region and C-terminal levels correlated with MMSE scores (mid-region rho = -0.22, p = 0.006; C-terminal rho = -0.19, p = 0.016; N-terminus rho = -0.14, p = 0.069). Conclusion Our novel assays demonstrated good analytical and clinical performance. CSF beta-syn reliably indicates early synaptic degeneration in AD. The mid-region assay uniquely differentiated SCD-AD from AD-dem, showing promise for early disease detection.
引用
收藏
页数:16
相关论文
共 50 条
[31]   Neuroanatomical and cognitive correlates of domain-specific anosognosia in early Alzheimer's disease [J].
Valera-Bermejo, Jose Manuel ;
De Marco, Matteo ;
Mitolo, Micaela ;
McGeown, William J. ;
Venneri, Annalena .
CORTEX, 2020, 129 :236-246
[32]   Sodium signal intensity of CSF using 1H-guided 23Na-MRI as a potential noninvasive biomarker in Alzheimer's disease [J].
Kerl, Hans-Ulrich ;
Baazaoui, Hakim ;
Herrmann, Katrin ;
Adlung, Anne ;
Ludwig, Nadia K. ;
Hausner, Lucrezia ;
Froelich, Lutz ;
Schad, Lothar ;
Groden, Christoph ;
Mohamed, Sherif A. .
JOURNAL OF NEUROIMAGING, 2024, 34 (05) :619-626
[33]   Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice [J].
Karikari, Akua A. ;
McFleder, Rhonda L. ;
Ribechini, Eliana ;
Blum, Robert ;
Bruttel, Valentin ;
Knorr, Susanne ;
Gehmeyr, Mona ;
Volkmann, Jens ;
Brotchie, Jonathan M. ;
Ahsan, Fadhil ;
Haack, Beatrice ;
Monoranu, Camelia-Maria ;
Keber, Ursula ;
Yeghiazaryan, Rima ;
Pagenstecher, Axel ;
Heckel, Tobias ;
Bischler, Thorsten ;
Wischhusen, Joerg ;
Koprich, James B. ;
Lutz, Manfred B. ;
Ip, Chi Wang .
BRAIN BEHAVIOR AND IMMUNITY, 2022, 101 :194-210
[34]   Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia [J].
Chiasserini, Davide ;
Biscetti, Leonardo ;
Eusebi, Paolo ;
Salvadori, Nicola ;
Frattini, Giulia ;
Simoni, Simone ;
De Roeck, Naomi ;
Tambasco, Nicola ;
Stoops, Erik ;
Vanderstichele, Hugo ;
Engelborghs, Sebastiaan ;
Mollenhauer, Brit ;
Calabresi, Paolo ;
Parnetti, Lucilla .
ALZHEIMERS RESEARCH & THERAPY, 2017, 9
[35]   Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Aβ(1-42), pTau and tTau CSF immunoassays [J].
Blennow, Kaj ;
Shaw, Leslie M. ;
Stomrud, Erik ;
Mattsson, Niklas ;
Toledo, Jon B. ;
Buck, Katharina ;
Wahl, Simone ;
Eichenlaub, Udo ;
Lifke, Valeria ;
Simon, Maryline ;
Trojanowski, John Q. ;
Hansson, Oskar .
SCIENTIFIC REPORTS, 2019, 9 (1)
[36]   CSF neurogranin levels as a biomarker in Alzheimer's disease and frontotemporal lobar degeneration: a cross-sectional analysis [J].
Jurasova, Vanesa ;
Andel, Ross ;
Katonova, Alzbeta ;
Veverova, Katerina ;
Zuntychova, Terezie ;
Horakova, Hana ;
Vyhnalek, Martin ;
Kolarova, Tereza ;
Matoska, Vaclav ;
Blennow, Kaj ;
Hort, Jakub .
ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
[37]   Connected Speech Deficit as an Early Hallmark of CSF-defined Alzheimer's Disease and Correlation with Cerebral Hypoperfusion Pattern [J].
Mazzon, Giulia ;
Ajcevic, Milos ;
Cattaruzza, Tatiana ;
Menichelli, Alina ;
Guerriero, Michele ;
Capitanio, Selene ;
Pesavento, Valentina ;
Dore, Franca ;
Sorbi, Sandro ;
Manganotti, Paolo ;
Marini, Andrea .
CURRENT ALZHEIMER RESEARCH, 2019, 16 (06) :483-494
[38]   Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease [J].
Whelan, Christopher D. ;
Mattsson, Niklas ;
Nagle, Michael W. ;
Vijayaraghavan, Swetha ;
Hyde, Craig ;
Janelidze, Shorena ;
Stomrud, Erik ;
Lee, Julie ;
Fitz, Lori ;
Samad, Tarek A. ;
Ramaswamy, Gayathri ;
Margolin, Richard A. ;
Malarstig, Anders ;
Hansson, Oskar .
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01)
[39]   Association of CSF CD40 levels and synaptic degeneration across the Alzheimer's disease spectrum [J].
Ye, Xinwu ;
Zhou, Wenjun ;
Zhang, Jie ;
Weiner, Michael W. ;
Aisen, Paul ;
Weiner, Michael ;
Petersen, Ronald ;
Jack, Clifford R., Jr. ;
Jagust, William ;
Trojanowki, John Q. ;
Toga, Arthur W. ;
Beckett, Laurel ;
Green, Robert C. ;
Saykin, Andrew J. ;
Morris, John ;
Shaw, Leslie M. ;
Khachaturian, Zaven ;
Sorensen, Greg ;
Carrillo, Maria ;
Kuller, Lew ;
Raichle, Marc ;
Paul, Steven ;
Davies, Peter ;
Fillit, Howard ;
Hefti, Franz ;
Holtzman, David ;
Mesulam, M. Marcel ;
Potter, William ;
Snyder, Peter ;
Lilly, Eli ;
Logovinsky, Veronika ;
Montine, Tom ;
Jimenez, Gustavo ;
Donohue, Michael ;
Gessert, Devon ;
Harless, Kelly ;
Salazar, Jennifer ;
Cabrera, Yuliana ;
Walter, Sarah ;
Hergesheimer, Lindsey ;
Harvey, Danielle ;
Bernstein, Matthew ;
Fox, Nick ;
Thompson, Paul ;
Schuff, Norbert ;
DeCArli, Charles ;
Borowski, Bret ;
Gunter, Jeff ;
Senjem, Matt ;
Vemuri, Prashanthi .
NEUROSCIENCE LETTERS, 2019, 694 :41-45
[40]   Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease [J].
Thorsell, Annika ;
Bjerke, Maria ;
Gobom, Johan ;
Brunhage, Eva ;
Vanmechelen, Eugeen ;
Andreasen, Niels ;
Hansson, Oskar ;
Minthon, Lennart ;
Zetterberg, Henrik ;
Blennow, Kaj .
BRAIN RESEARCH, 2010, 1362 :13-22